MDT
55
3
FCX
58
5
DOW
63
5
SBUX
44
3
MLM
58
5
HRB
73
3
GD
59
2
HAS
57
2
QRVO
38
5
HBAN
48
3
ROST
62
2
LRCX
46
4
APH
53
5
CMG
54
4
DOV
69
6
AXP
69
2
DFS
59
5
ZTS
58
-5
RRC
52
2
TROW
39
4
MDT
55
3
FCX
58
5
DOW
63
5
SBUX
44
3
MLM
58
5
HRB
73
3
GD
59
2
HAS
57
2
QRVO
38
5
HBAN
48
3
ROST
62
2
LRCX
46
4
APH
53
5
CMG
54
4
DOV
69
6
AXP
69
2
DFS
59
5
ZTS
58
-5
RRC
52
2
TROW
39
4
Financhill
Back

Edgewise Therapeutics Vs. Catalyst Pharmaceuticals Industry Stock Comparison

Buy
90

EWTX
Edgewise Therapeutics

Last Price:
29.51
Seasonality Move:
-4.53%
Sell
49

CPRX
Catalyst Pharmaceuticals

Last Price:
21.34
Seasonality Move:
-9.09%
Buy
90
Edgewise Therapeutics (EWTX) is a Buy

Is Edgewise Therapeutics a Buy, Sell or Hold?

  • The current Edgewise Therapeutics [EWTX] share price is $29.50. The Score for EWTX is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
  • EWTX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
49
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $21.36. The Score for CPRX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EWTX Stock Price Chart

What is Edgewise Therapeutics's stock price today?

  • The Edgewise Therapeutics share price today is $29.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $21.36
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

EWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.79 Buy
Relative Strength Index (14 RSI): 78.49 Buy
Chaikin Money Flow: 9542700 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.59 - 21.35) Buy
Bollinger Bands (100): (16.57 - 20.61) Buy

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.5 Buy
Relative Strength Index (14 RSI): 70.42 Buy
Chaikin Money Flow: 901932 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.72 - 20.62) Buy
Bollinger Bands (100): (15.22 - 19.16) Buy

EWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.25 Buy
20-day SMA: 18.87 Buy
50-day SMA: 18.94 Buy
200-day SMA: 16.56 Buy
8-day EMA: 20.59 Buy
20-day EMA: 19.2 Buy
50-day EMA: 18.74 Buy
200-day EMA: 16.34 Buy

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.25 Buy
20-day SMA: 20.17 Buy
50-day SMA: 18.73 Buy
200-day SMA: 16.16 Buy
8-day EMA: 20.45 Buy
20-day EMA: 20.02 Buy
50-day EMA: 18.92 Buy
200-day EMA: 16.55 Buy

Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.05 per share, and a decrease next year of $0.35 per share.

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.10 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.

Edgewise Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):